|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 296.86 USD | -0.08% |
|
-1.31% | -2.02% |
| 07-01 | Activist investors make bigger push for campaigns in H1, seek more M&A | RE |
| 06-03 | Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM |
| Market Cap | 7.94B 6.94B 6.38B 5.95B 11.28B 756B 11.45B 76.6B 29.78B 372B 29.81B 29.17B 1,281B | P/E 2026 * |
35.7x | P/E 2027 * | 34.9x |
|---|---|---|---|---|---|
| Enterprise Value | 7.19B 6.29B 5.78B 5.39B 10.22B 685B 10.37B 69.38B 26.97B 337B 27B 26.42B 1,160B | EV / Sales 2026 * |
2.8x | EV / Sales 2027 * | 2.65x |
| Free-Float |
60.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | -0.08% | ||
| 1 week | -1.31% | ||
| Current month | +1.11% | ||
| 1 month | -2.61% | ||
| 3 months | +6.03% | ||
| 6 months | -2.75% | ||
| Current year | -2.02% |
| 1 week | 287.94 |  | 302.55 |
| 1 month | 270 | | 307.35 |
| Current year | 236.73 | | 328.56 |
| 1 year | 236.73 | | 343.12 |
| 3 years | 211.43 | | 431.79 |
| 5 years | 211.43 | | 832.7 |
| 10 years | 140.53 | | 832.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 01/01/2003 |
| President | 61 | 09/09/2024 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 15/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 01/01/2012 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 25/04/2017 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 25/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-11 | Sell | Executive/Senior Manager | -550 | 0.0025% | ||
| 04-24 | Fiscal year | General Counsel | 449 | 0.0020% | ||
| 04-24 | Fiscal year | Chief Financial Officer | 2,576 | 0.0117% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.08% | -1.31% | +18.01% | -21.37% | 7.94B | |
| +3.49% | +1.36% | -29.04% | -11.02% | 166B | |
| +5.04% | +2.73% | -5.88% | -4.53% | 106B | |
| +2.80% | +3.63% | +0.09% | +55.31% | 57.69B | |
| +1.33% | +1.39% | +53.16% | +49.84% | 53.78B | |
| +3.39% | +1.39% | -10.26% | -39.65% | 43.56B | |
| +3.50% | +11.11% | - | - | 36.52B | |
| +3.47% | +1.58% | -14.08% | -43.91% | 27.49B | |
| +0.20% | +4.24% | +64.56% | -3.33% | 25.84B | |
| +2.78% | +1.17% | -8.15% | -0.43% | 21.27B | |
| Average | +2.59% | +4.16% | +7.60% | -2.12% | 54.67B | |
| Weighted average by Cap. | +3.26% | +3.74% | -3.50% | +0.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.57B 2.24B 2.06B 1.92B 3.65B 244B 3.7B 24.76B 9.63B 120B 9.64B 9.43B 414B | 2.63B 2.3B 2.12B 1.97B 3.74B 251B 3.8B 25.41B 9.88B 123B 9.89B 9.68B 425B |
| Net income | 225M 197M 181M 168M 319M 21.41B 324M 2.17B 843M 10.52B 844M 826M 36.26B | 230M 201M 185M 172M 326M 21.87B 331M 2.22B 861M 10.75B 862M 844M 37.05B |
| Net Debt | -749M -655M -602M -561M -1.06B -71.32B -1.08B -7.22B -2.81B -35.06B -2.81B -2.75B -121B | -965M -844M -776M -723M -1.37B -91.92B -1.39B -9.31B -3.62B -45.18B -3.62B -3.55B -156B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | $296.86 | -0.08% | 344,714 |
| 01/07/26 | $297.09 | +1.19% | 204,201 |
| 30/06/26 | $293.61 | -0.57% | 237,364 |
| 29/06/26 | $295.30 | -1.83% | 329,344 |
| 26/06/26 | $300.79 | +0.84% | 481,973 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
Select your edition
All financial news and data tailored to specific country editions
